Nervgen Pharma (NGEN) Invested Capital (2024 - 2025)
Nervgen Pharma's Invested Capital was $2.5 million in the quarter ended Dec 31, 2025, up 30.6% from $1.91 million a year earlier.
Powered by 
Analysis
Nervgen Pharma (NGEN) Invested Capital (2024 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, Invested Capital at Nervgen Pharma came in at $2.49 million, up 27.7% from the prior year.
- In earlier years, Invested Capital was $1.95 million in the year ended Dec 31, 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 88.79 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 134.01 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 64.89 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 95.89 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 79.44 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 50.26 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 68.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 38.08 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 148.69 Bn |
| 10 | Nervgen Pharma | 140.18 Mn | 140.18 Mn | - | - |
API Access
Nervgen Pharma Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=NGEN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "NGEN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=NGEN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();